The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| PRPO | +190.72% | -67.54% | -20.13% | -99% |
| S&P | +13.95% | +78.35% | +12.25% | +186% |
Precipio, Inc.is a cancer diagnostics and reagent technology company, which provides diagnostic products and services to the oncology market. Its products include ICP, HemeScreen, and IV-Cell, and services include primary diagnostic, SmartPath, SmartGen, HemeScreen Panel, and ICE COLD-PCR. The company was founded on March 6, 1997 and is headquartered in New Haven, CT.
No news articles found for Precipio.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $6.77M | 29.9% |
| Gross Profit | $2.57M | 29.8% |
| Gross Margin | 37.95% | 0.0% |
| Market Cap | $28.81M | 190.1% |
| Market Cap / Employee | $480.20K | 0.0% |
| Employees | 60 | 0.0% |
| Net Income | -$79.00K | 87.4% |
| EBITDA | $376.00K | 252.2% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $2.31M | 118.9% |
| Accounts Receivable | $1.96M | 91.7% |
| Inventory | 0.8 | 33.6% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $2.95M | 458.9% |
| Short Term Debt | $611.00K | -18.8% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -6.58% | 10.1% |
| Return On Invested Capital | -49.98% | 12.4% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$44.00K | 35.3% |
| Operating Free Cash Flow | $10.00K | -75.6% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 0.69 | 0.77 | 1.42 | 2.20 | 164.07% |
| Price to Sales | 0.45 | 0.47 | 0.83 | 1.28 | 124.31% |
| Price to Tangible Book Value | -51.00 | 41.62 | 247.87 | 30.17 | -148.92% |
| Price to Free Cash Flow TTM | 38.31 | 13.44 | 31.31 | 49.46 | - |
| Enterprise Value to EBITDA | 72.66 | -24.07 | -47.69 | 80.82 | -296.78% |
| Free Cash Flow Yield | 2.6% | 7.4% | 3.2% | 2.0% | - |
| Return on Equity | -32.3% | -25.3% | -14.8% | -9.8% | -59.52% |
| Total Debt | $1.25M | $2.23M | $2.61M | $3.56M | 178.28% |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
